Left Ventricular Dysfunction

AI-Enabled ECG as a New Surveillance Tool for Left Ventricular Dysfunction in Hypertrophic Cardiomyopathy on Mavacamten

By MedXY 08/12/2026

This study explores the potential of an AI-powered ECG tool to monitor left ventricular systolic dysfunction in hypertrophic cardiomyopathy patients treated with mavacamten, offering a less burdensome alternative to frequent echocardiograms.

Cardiology news OB/GYN & Women’s Health

Exploring the Impact of Multiple Pregnancies on Subclinical Left Ventricular Function in Healthy Women

By MedXY 08/04/2026

This study reveals that higher parity is associated with subtle reductions in myocardial strain during pregnancy, suggesting cumulative cardiovascular effects despite normal ejection fraction.

Cardiology Neurology news

Apixaban Versus Aspirin for Recurrent Stroke Prevention in Patients with Left Ventricular Dysfunction: Insights from a Secondary Analysis of the ARCADIA Trial

By MedXY 10/29/2025

A secondary analysis of the ARCADIA trial reveals that apixaban significantly reduces recurrent ischemic stroke risk compared to aspirin in patients with left ventricular systolic dysfunction post-cryptogenic stroke.